Market Overview

Here's How A Technician Views Monsanto

Related MON
These Non-Tech Companies Are Investing In An AI Future
Benzinga's Top Upgrades, Downgrades For July 12, 2017
Exane Asset Management Buys Monsanto Co, Biogen Inc, Qiagen NV, Sells Citigroup Inc, W R Grace, ... (GuruFocus)

Monsanto Company (NYSE: MON) rose from the low $40s in 2010 to nearly $130 in 2014. Since making that short-term peak nearly a year ago, however, the stock has been grinding through a sideways consolidation in a range between $105 and $130.

With the stock almost smack in the middle of that range currently, its future trajectory is unobvious. Below is a quick peek at the fundamentals and technicals, which should provide a better idea of Monsanto's future.

What The Bulls See

  • A 1.7 percent dividend yield
  • Some cheap valuation metrics:
    • An estimated enterprise value of $61.78 billion versus a market capitalization of $57.09
    • A price-to-sales ratio of 3.83
  • Net profit margins of 15.86 percent, which spin off over $1.6 billion in positive levered free cash flow annually
  • Very good management effectiveness metrics:
    • A return-on-assets of 9.75 percent
    • A return-on-equity of 21.91 percent
  • A current ratio of 1.96, which signifies financial stability for the company in the short-term
  • What The Bears See

  • Some expensive valuation metrics:
    • A price-to-book ratio of 7.59
    • A P/E ratio of nearly 17 versus estimated revenue and EPS growth for next year of 6.1 percent and 16.1 percent, respectively
  • Some iffy balance sheet measurables:
    • Total cash of $2.72 billion versus total debt of $8.31 billion
    • A debt-to-equity ratio of 108.39 percent
  • Related Link: ScottsMiracle-Gro Reports Amended Deal With Monsanto

    The Technical Take

    Technicians note that Monsanto shares seem to be nearly in the middle of long-term support and resistance at this point.

    The monthly chart of MON shares show monthly closing resistance coming in at $127.40 and monthly horizontal line support coming in at $106.82.

    With the stock currently at $118.42, the middle of the support – resistance range is just below current levels. The stock, they further note, is in an uptrend and will remain so as long as the $105–$106 range holds up as support.

    If the stock can make it through the monthly closing resistance at $127.40, the next projected resistance comes in at around $145.

    Buyers will likely be coming in aggressively on either a test of support at $105–$106 or on a breakout and subsequent re-test of the $127–$130 resistance range.


    Monsanto is far from a perfect company, despite the long-term strength the stock has shown in the last five years. With some blemishes on the overall picture, prudent buyers will be waiting for more opportune price levels in which to make sizable entries.

    On the other hand, short-sellers have to be cautious about making significant bets against a stock that has shown such long-term resilience.

    Image Credit: Public Domain

    Posted-In: Long Ideas Dividends Technicals Movers Trading Ideas


    Related Articles (MON)

    View Comments and Join the Discussion!